This study further investigated the relationship between pioglitazone use and the risk of developing Alzheimer's disease (AD) in patients newly diagnosed with T2DM, and examined the potential impact of insulin use on this association. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.